Jiujiang Shanshui Technology Co.,Ltd

Jiujiang Shanshui Technology Co.,Ltd., established in 2012 and headquartered in Jiujiang, China, is a company dedicated to the innovation, manufacturing, and distribution of chemical intermediates. Its commercial activities primarily focus on the Chinese market, supplying crucial components for the production of dyes, agricultural products (pesticides), and pharmaceuticals. The company's extensive product catalog includes specialized compounds such as 6-nitro-1,2-diazooxynaphthalene-4-sulfonic acid, 1,2-diazooxynaphthalene-4-sulfonic acid, 5-nitro-2-aminophenol, 2-chloropyridine, and anthranilic acid. Other notable offerings comprise 4-nitro-2-aminophenol, O-aminophenol, 3-nitrophthalic acid, as well as distinct intermediates like 3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxylic acid (referred to as pyrazole acid), 2-amino-5-chloro-3,N-dimethylbenzamide (known as K amine), and 2-chloro-5-aminophenol.

Jiujiang Shanshui Technology Co.,Ltd trades as 301190.SZ on SHZ. The company is classified in Basic Materials / Chemicals - Specialty and reports in CNY.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Jiujiang Shanshui Technology Co.,Ltd can be compared against peers such as Jiangsu Jiuding New Material Co., Ltd., Shandong Sinobioway Biomedicine Co., Ltd., Shenzhen WOTE Advanced Materials Co., Ltd, Shanxi Huhua Group Co., Ltd., Shanghai Anoky Group Co., Ltd, Hunan Lead Power Dazhi Technology Incorporated Company.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $4.25B, beta of 0.72, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

301190.SZ currently shows total debt of N/A and beta of 0.72. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.jjsskj.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.